Member Info for UglyButler

Would be nice

The gold standard FDA approved circulating Tumour cell harvesting system that nobody wants

I'd hope for an update on the appeal on the adverse decision from the larger case as advised in the September trade update. I know the wheels of justice are slow but surely a decision will be due soon

Results due in Feb according to the web site - it always gives a sloppy impression when companies rush out a revised date at the last minute - 2 more days to go tick tock tick tock

Supermarkets are great value right now - Sainsbury's Tesco all up and M&S lagging. However food is doing well and the turnaround plan is making strong progress particularly in the occupation of former Debenhams sites - The bank of England predicts the recession will be shorter and shallower and the typical MKS customer is the most protected demographic against economic shocks in any case - goodbye mediocrity hello £2 plus

https://www-dailyecho-co-uk.cdn.ampproject.org/c/s/www.dailyecho.co.uk/news/23241505.amp/

I think AN knows the company lacks the scale to get this commercialised and the big boys won't let the upstart in if it's going to steal their lunch. That's why we have an M&A specialist on board at the same time as the update. AN wants to keep AGL autonomous but the clock is ticking now given this look lacklustre performance

If $412 million is the US figure - which represents about a third of world sales that would be a good start plus an on going royalty

Cash burn - the 22 million includes one offs like setting up the labs. The streamlined structure and lower required capital should see the cash past until H2 24

The crash in confidence is understandable but might flush out a buyer

There is no need to rush into averaging down just yet as could sink further on lack of positive news

I think Newland recognises he will need to deliver or face losing control of his baby and I'm in no doubt there is value here but each to their own

Seasoned AGL investors will continue to be patient while the lab accreditations are realised. Still lots to play for in 2023 and not spitting my dummy out just yet

A weak pound; a low SP - great update and a tasty portfolio

The pizza machines will turbo charge the business - any in the UK yet ?

In other words the dog ate my homework

I'll be adding soon. This is looking like a great opportunity to top up. This isn't a sexy share but it's come a long way since Lakehouse and has 23 million cash plus a fat order book. I got mine in the mid 30's

I'd prefer to see continued investment in the business

No I'm still in - profit ahead of expectations just need to emulate HAT

Parsortix can work for multiple cancers and the FDA process will not be so protracted

They need the labs to be accredited and a few more contracts to get momentum back in the SP

For now fill your boots

I just hope the new sales director is capable of achieving results. Seems like a risky strategy to me. Red leg has vanished from super market shelves

Wait for a proper offer the bod selling us short again

Unlikely